News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,414 Results
Type
Article (42436)
Company Profile (293)
Press Release (696673)
Multimedia
Podcasts (95)
Webinars (18)
Section
Business (210208)
Career Advice (2193)
Deals (36334)
Drug Delivery (123)
Drug Development (81766)
Employer Resources (176)
FDA (16642)
Job Trends (15457)
News (354146)
Policy (33686)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2659)
Accelerated approval (31)
Adcomms (25)
Allergies (141)
Alliances (51501)
ALS (167)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (309)
Approvals (16894)
Artificial intelligence (523)
Autoimmune disease (143)
Automation (38)
Bankruptcy (368)
Best Places to Work (12015)
BIOSECURE Act (21)
Biosimilars (191)
Biotechnology (186)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (638)
Cancer (4787)
Cardiovascular disease (402)
Career advice (1858)
Career pathing (36)
CAR-T (279)
CDC (53)
Celiac Disease (2)
Cell therapy (748)
Cervical cancer (36)
Clinical research (69748)
Collaboration (1709)
Company closure (4)
Compensation (1165)
Complete response letters (54)
COVID-19 (2767)
CRISPR (90)
C-suite (827)
Cystic fibrosis (143)
Data (6176)
Decentralized trials (2)
Denatured (30)
Depression (131)
Diabetes (496)
Diagnostics (6858)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (248)
Drug pricing (200)
Drug shortages (29)
Duchenne muscular dystrophy (226)
Earnings (91079)
Editorial (61)
Employer branding (21)
Employer resources (154)
Events (119870)
Executive appointments (991)
FDA (19750)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1463)
Gene editing (196)
Generative AI (42)
Gene therapy (596)
GLP-1 (978)
Government (4897)
Grass and pollen (7)
Guidances (384)
Healthcare (19646)
HIV (56)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (246)
Immuno-oncology (55)
Indications (103)
Infectious disease (3034)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (113)
Intellectual property (243)
Interviews (350)
IPO (16862)
IRA (53)
Job creations (3785)
Job search strategy (1546)
JPM (57)
Kidney cancer (15)
Labor market (84)
Layoffs (560)
Leadership (32)
Legal (8160)
Liver cancer (91)
Longevity (14)
Lung cancer (641)
Lymphoma (371)
Machine learning (43)
Management (61)
Manufacturing (805)
MASH (164)
Medical device (14107)
Medtech (14160)
Mergers & acquisitions (20549)
Metabolic disorders (1266)
Multiple sclerosis (156)
NASH (16)
Neurodegenerative disease (309)
Neuropsychiatric disorders (87)
Neuroscience (2898)
Neurotech (1)
NextGen: Class of 2026 (6849)
Non-profit (4778)
Now hiring (65)
Obesity (595)
Opinion (272)
Ovarian cancer (164)
Pain (198)
Pancreatic cancer (224)
Parkinson's disease (281)
Partnered (33)
Patents (491)
Patient recruitment (474)
Peanut (57)
People (60793)
Pharmaceutical (64)
Pharmacy benefit managers (31)
Phase 1 (21745)
Phase 2 (30688)
Phase 3 (22860)
Pipeline (5110)
Policy (300)
Postmarket research (2585)
Preclinical (9239)
Press Release (70)
Prostate cancer (236)
Psychedelics (50)
Radiopharmaceuticals (282)
Rare diseases (824)
Real estate (6291)
Recruiting (69)
Regulatory (25023)
Reports (51)
Research institute (2474)
Resumes & cover letters (372)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (148)
Series A (239)
Series B (185)
Service/supplier (17)
Sickle cell disease (97)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (45)
Startups (3693)
State (2)
Stomach cancer (17)
Supply chain (107)
Tariffs (88)
The Weekly (63)
Vaccines (1014)
Venture capital (87)
Weight loss (384)
Women's health (88)
Worklife (21)
Date
Today (8)
Last 7 days (601)
Last 30 days (2229)
Last 365 days (30251)
2026 (2858)
2025 (30660)
2024 (35719)
2023 (40631)
2022 (51793)
2021 (56499)
2020 (55286)
2019 (48362)
2018 (36535)
2017 (32918)
2016 (32462)
2015 (38550)
2014 (32138)
2013 (27178)
2012 (29472)
2011 (30161)
2010 (28089)
Location
Africa (778)
Alabama (84)
Alaska (7)
Arizona (313)
Arkansas (14)
Asia (40303)
Australia (6596)
California (11218)
Canada (3279)
China (1090)
Colorado (475)
Connecticut (474)
Delaware (339)
Europe (88234)
Florida (1682)
Georgia (359)
Hawaii (4)
Idaho (65)
Illinois (889)
India (65)
Indiana (520)
Iowa (23)
Japan (423)
Kansas (127)
Kentucky (41)
Louisiana (27)
Maine (72)
Maryland (1401)
Massachusetts (8075)
Michigan (326)
Minnesota (629)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (125)
New Hampshire (79)
New Jersey (2997)
New Mexico (29)
New York (2968)
North Carolina (1503)
North Dakota (9)
Northern California (5465)
Ohio (346)
Oklahoma (23)
Oregon (43)
Pennsylvania (2275)
Puerto Rico (22)
Rhode Island (47)
South America (1163)
South Carolina (65)
South Dakota (1)
Southern California (4362)
Tennessee (175)
Texas (1756)
United States (40073)
Utah (340)
Vermont (1)
Virginia (263)
Washington D.C. (84)
Washington State (920)
West Virginia (4)
Wisconsin (110)
Wyoming (2)
739,414 Results for "pace analytical services inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InnotiveDx Wins £1 million Grant From PACE
November 26, 2025
·
2 min read
Earnings
‘We’re Not Done’: Roche Plans To Sustain Dealmaking Pace After 89bio
Roche has already signed several high-ticket deals this year, including the $3.5 billion acquisition of 89bio and Genentech’s $2.1 billion molecular glue pact with Orionis Biosciences.
October 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace
December 17, 2025
·
4 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Press Releases
Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026
December 10, 2025
·
7 min read
Press Releases
Pace Surgical Receives FDA 510(k) Clearance for Ultra Compression Screw System for Foot and Ankle Reconstruction
November 13, 2025
·
4 min read
Press Releases
Medtronic initiates global pivotal study of cardiac pacing in a new patient population
September 16, 2025
·
5 min read
Press Releases
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
December 23, 2025
·
4 min read
Press Releases
Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference
December 16, 2025
·
1 min read
Press Releases
NanoMosaic Secures FDA Advanced Manufacturing Technology (AMT) Designation for Advanced Gene Therapy Analytics
January 29, 2026
·
3 min read
1 of 73,942
Next
